Cellular Therapy in 2024: What, Why, When, Who… and Where Are We Goi…

University of Colorado Department of Medicine

J. Gutman

CAR T-Cell Therapy in Autoimmune Disorders

Vanderbilt University Medical Center (VUMC)

O. Oluwole

Y90 Radioembolization for Locally Advanced HCC

UCLA Health

S. Padia

Drug Allergy

Mariana Castells

Endocrine Adverse Events From Checkpoint Inhibitors

Yale Cancer Center

K. Herold

The Expanding World of CAR T-Cell Therapy

UNC Lineberger Comprehensive Cancer Center

F. Brianne Buchanan

CAR NK Cells: Next Generation Cell Therapies for Cancer

University of Colorado Cancer Center

K. Rezvani

CAR T-Cell vs. Bispecific Therapies for Blood Cancers: How Oncologis…

GRACE

A. Goodman, A. Jeong, S. Rajeeve

SIR 2024 Insights: Route90 US IDE Pivotal Study Early Results in Rad…

SIR 2024 Insights

A. Kennedy

HCC Percutaneous Radio-Ablation Using BAT-90: Results of an Ongoing …

Malkhaz Mizandari

2024 Update on CAR T-Cell Therapies: Immunoinflammatory Toxicities

Cleveland Clinic Taussig Cancer Institute

P. Caimi

The Improbable History of CAR T-Cells

Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

C. June

Bispecific vs. Combination Therapy - PRO Combination Therapy

ImmunoTherapy Bridge 2023

A. Patnaik

Bispecific vs. Combination Therapy - PRO Bispecific

ImmunoTherapy Bridge 2023

J. Gulley

Treatment of Symptomatic Brain Metastases in Melanoma: Combination o…

Melanoma Bridge 2023

H. Tawbi

Innovating Immunotherapy for Pancreatic Cancer

ImmunoTherapy Bridge 2023

G. Lesinski

CAR-T 101: Overview of CAR-T Therapy and Management of Toxicities

UNC Lineberger Comprehensive Cancer Center

M. Mcelfresh

Novel Insights Into the Mechanisms of Radiation-Induced Anti-Tumor I…

ImmunoTherapy Bridge 2023

S. Demaria

Engineered T-Cells

Melanoma Bridge 2023

O. Michielin

IDWeek 2023 Insights: Managing Infectious Complications and Infectio…

Insights from IDWeek 2023

T. Patel